Skip to main content
Tech.euFundingExplorerBeta

bit.bio

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.

bit.bio has raised €154M across 3 funding rounds from 9 investors, most recently a Series D+ round in Nov 2026. Based in Cambridge, UK; active in Healthtech. Data as of Nov 2026.

Cambridge, UKbit.bio ↗
Total raised
€154M
€153,907,117
Funding rounds
3
Investors
9
distinct backers
Active since
2021-11
latest 2026-11

Funding by year

EUR raised per year · 2026 YTD
bit.bio — funding by year — interactive chart.
Data table
bit.bio — funding by year
2021€89M
2026€65M

Signals

High confidence
Raise-next likelihood16
base rate 53% for Series D+
  • ▼ Raised very recently
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood24
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 5y since founding (typical exit age)
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector, similar size

Global coverage: FundingData